Melissa S F Ng1, Immanuel Kwok1, Leonard Tan1

  • 1Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore.

Science (New York, N.Y.)
|January 11, 2024
PubMed
概括

透瘤的中性粒细胞发生不可逆转的变化,成为一个独特的dcTRAIL- R1+状态,促进瘤生长. 针对这种中性粒细胞重编程可能会增强癌症免疫疗法.